Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DualStim Therapy + umbilical cord-derived Wharton's Jelly
- Development stage
- Unknown
- Lead developer
- BioIntegrate
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intracavernosal (Wharton’s Jelly), Device/Procedural (DualStim Therapy/ESWT)
01
Overview
DualStim Therapy + umbilical cord-derived Wharton's Jelly is a therapeutic combination specifically evaluated for the treatment of moderate to severe erectile dysfunction. DualStim Therapy employs a combination of *focused* and *radial low-intensity extracorporeal shock wave therapy (ESWT)*, aiming to stimulate angiogenesis and tissue regeneration in the corpora cavernosa. This is paired with *intracavernosal injection* of a formulated preparation of Wharton’s Jelly derived from human umbilical cord tissue, which is rich in mesenchymal stem cells, growth factors, cytokines, hyaluronic acid, extracellular vesicles, collagen, and sulfated proteoglycans. The stem cells and bioactive components of Wharton’s Jelly are hypothesized to promote tissue repair, modulate inflammation, and enhance vascularization in penile tissues to restore erectile function. This combination aims for potential synergistic effects between mechanical stimulation (by ESWT) and the regenerative properties of the biologic product[1][2].
- Other names
- DualStim Therapy + Wharton's JellyDualStim + WJ
Beyond the preview
Go deeper on DualStim Therapy + umbilical cord-derived Wharton's Jelly.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DualStim Therapy + umbilical cord-derived Wharton's Jelly.